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A novel data fusion method for the 
effective analysis of multiple panels 
of flow cytometry data
Gerjen H. tinnevelt  1,2, Selma van staveren2,3, Kristiaan Wouters4, Erwin Wijnands5, 
Kenneth Verboven6,7, Rita Folcarelli1, Leo Koenderman  3, Lutgarde M. C. Buydens1  
& Jeroen J. Jansen1
Multicolour flow cytometry (MFC) is used to measure multiple cellular markers at the single-cell level. 
Cellular markers may be coloured with different panels of fluorescently-labelled antibodies to enable 
cell identification or the detection of activated cells in pre-defined, ‘gated’ specific cell subsets. The 
number of markers that can be used per measurement is technologically limited however, requiring 
every panel to be analysed in a separate aliquot measurement. The combined analyses of these 
dedicated panels may enhance the predictive ability of these measurements and could enrich the 
interpretation of the immunological information. Here we introduce a fusion method for MFC data, 
based on DAMACY (Discriminant Analysis of Multi-Aspect Cytometry data), which can combine 
information from complementary panels. This approach leads to both enhanced predictions and clearer 
interpretations in comparison with the analysis of separate measurements. We illustrate this method 
using two datasets: the response of neutrophils evoked by a systemic endotoxin challenge and the 
activated immune status of the innate cells, T cells and B cells in obese versus lean individuals. The data 
fusion approach was able to detect cells that do not individually show a difference between clinical 
phenotypes but do play a role in combination with other cells.
Multicolour flow cytometry (MFC) is a powerful analytical platform used to measure multiple cellular markers 
in potentially very large samples (>10,000 cells) at the single-cell level. The detection of certain cells or cellular 
activation states with specific combinations of expressed cellular markers may enable the discrimination of an 
immune response; however, the number of cellular markers usable in each MFC measurement is technologically 
limited by the spectral overlap between the fluorescent dyes. This limitation may reduce the cellular diversity 
detected within a sample, as several studies have revealed that simultaneously combining more markers leads to a 
more detailed view of the immune system in which a greater cell variability can be discerned1.
Ideally, the complete cellular heterogeneity should be measured using single-cell omics2. Cells with specific 
marker expressions that are not by themselves predictive may support predictions based on other cells and the 
covariance between the cell types. Multivariate data analysis methods should only highlight the relevant cellular 
variability for the studied clinical phenotype. A single cell (sub)type may not describe the whole system, but 
reporting the complete cellular variability may mask the most important differences in the studied clinical phe-
notype. Moreover, the approach should ideally be data driven, enabling the identification of not only the cells 
predicted by the research hypothesis, but also the discovery of new cell (sub)types involved in the studied clinical 
phenotype.
To increase the number of measured parameters beyond the technical limitations of a given MFC setup, addi-
tional markers can be measured in multiple aliquots comprising different panels. Methods have been developed 
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to integrate the non-measured marker variability in all measured aliquots on basis of their overlapping markers; 
however, this implies that the panels mainly characterise the same cells. Experimental research is often aimed at 
investigating different cell types and their activation states, such as the complementary cell types that may interact 
during an immunological response, which is the specific biomedical information of interest. Measuring different 
cell types in the same sample is often achieved using distinct panels for each blood aliquot. For this reason, we 
focus this article on methods that describe the cell characteristics within a panel and combine these descriptions 
to classify immune responses.
Existing methods for analysing multiple panels of MFC data use one of the following three approaches. The 
first is to cluster the cells, for example using kmeans or manual sequential bivariate gating, and to create a distri-
bution of each sample over these clusters3. The second approach is to extract the important features from each 
marker in each panel, such as the mean, standard deviation and skewness, as is achieved using techniques such as 
Admire-LVQ4. The drawback of these two methods is that the quantitative single-cell marker expression is lost, 
which limits the interpretation of the data. The third approach creates 2D histograms of each pair of markers, 
which means the interpretation of the data is possible but tedious, as there are many pairwise combinations of 
markers5.
One of our recently developed methods, DAMACY, visualises the over- and underrepresented cells in an 
immune response measured in a case-control experiment6. This technique first creates a multidimensional his-
togram for each sample within a low-dimensional principal component space, which are then quantitatively 
compared between individuals in a second step using the discriminant analysis method Orthogonal Partial Least 
Squares Discriminant Analysis (OPLS-DA). OPLS-DA translates the histograms into a ‘cell map’, in which the 
multivariate marker expression patterns can be associated with the differential expression of the cells, which are 
represented as a contrast. The main advantage of this approach is that the original marker co-expressions may still 
be observed using this cell map, and can therefore be associated with the specific differentially abundant cells and 
to the diagnosis of the specific sample in which the cell is found.
The original implementation of DAMACY focussed on single-panel experiments; however, with relatively 
small adjustments, the second step involving the quantitative comparison of different histograms can be modified 
to allow the integration of data from multiple panels measured in the same samples6. We can extend the discrim-
inative step of DAMACY to incorporate the fusion of data from multiple measured aliquots to discern groups of 
samples based on the covariance between the cell populations they express within each panel, and the relation-
ships between the cell populations in the different panels. This may enhance the predictive ability of this approach 
in comparison with the analysis of a single panel because of the ‘multivariate advantage’7. The group of cells which 
are only predictive when in combination with other cell (sub)types, are thus considered essential constituents in 
the mechanisms that allow diagnosis, but would otherwise be overlooked in a model fitted on the cells within a 
single aliquot. This data fusion approach may also thereby enhance the interpretation of the diagnosis, by associ-
ating a larger variability of cells with the immune response. This method of data fusion will bring flow cytometry 
considerably closer to a single-cell omics approach, in which the full complement of cells may be included in a 
diagnosis and the associated mechanistic interpretation.
Results
We demonstrate the fusion of multiple panels of flow cytometry data from two case studies using DAMACY. 
The first dataset, on the in vivo effect of lipopolysaccharide (LPS) on gated blood neutrophils, consists of three 
different measured aliquots. The second dataset, investigating the effect of obesity on the immune system, was 
generated from two different aliquots, in which we could define three distinct subsets: T cells, B cells and innate 
cells, see methods for more information.
Lipopolysaccharide challenge. The intravenous administration of LPS (endotoxin) elicits an immune 
response that mimics the systemic inflammatory response syndrome in humans. Upon an LPS challenge, three 
neutrophil subsets can be identified in the peripheral blood, which are characterised by their different expression 
levels of CD16 and CD62L and their co-expression of other surface markers8. All three panels used therefore 
contained the markers CD16 and CD62L, and a set of various other markers to study their co-expression in these 
cells during the inflammatory response.
The individual aliquots had a decent accuracy of 98–100% for the prediction of the LPS response and control 
samples. The fusion model performed with 100% cross-validated accuracy, as shown in Table 1. The mean predic-
tion score of the individual fused samples are shown in Fig. 1a, which indicates a relatively severe LPS response 
among all modelled samples, with higher values indicating a more severe response. The three panels on the right 
(b, c, and d) indicate which areas in the principal component analysis (PCA) spaces of the different measured ali-
quots contain cells that are predictors for LPS (blue) or the control (red). Figure 1c shows the mature neutrophils 
(CD62L+CD16+; CM) associated with the control samples, and the immature neutrophils (CD62L+CD16dim; 
Accuracy Sensitivity Specificity
Aliquot 1 100% 100% 99%
Aliquot 2 97% 98% 97%
Aliquot 3 97% 100% 94%
Fusion 100% 100% 99%
Table 1. Cross-validated performance of the models for each dataset and the fusion of all three datasets.
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LI) and CD62L−CD16+ neutrophils (LM) associated with the LPS response samples. Immature CD62Llow neu-
trophils were also observed in the first and third aliquots (Fig. 1b,d). The immature neutrophils (LI) exhibited 
a relative low expression level for most markers, but did have a relatively high level of CD64. The mature neu-
trophils more abundant in the control samples (CM) showed a higher (co-)expression of CD181, CD182, CD88 
and TLR-4. The LPS-associated neutrophils (LM) had a higher (co-)expression of PDL-1, CBRM1/5, LAIR-1, 
CD32, CD49d, CD11b and CD66b. Another small subpopulation associated with the control samples could also 
be identified within aliquots 2 and 3, but was set to zero by the variable importance in projection (VIP) step (see 
Supplementary Fig. 1c,d). This subpopulation had a similar expression pattern to the LPS-associated mature 
neutrophils, but had a higher level of CD11b, CD11c, CD32, CD35, CD49d, CD66b and CD182 expression. This 
subpopulation was more abundant in the control samples in some individuals, while in other individuals the 
subpopulation was more abundant in the response sample, which would explain the lower prediction specificity 
of aliquots 2 and 3.
Effect of obesity on the immune system. In this study, we wanted to identify the differences in the circu-
lating immune cells of obese and lean individuals, based on markers measured in multiple aliquots. Discriminant 
models were separately built for each aliquot, as shown in Table 2. The models built on the innate cells and the T 
cells were able to discriminate obese from lean individuals (75% and 79% accuracy, respectively), while the model 
built using the B cell data had a lower predictive accuracy of 71%. The inclusion of the innate cell data resulted 
in a large increase in accuracy compared to models using only the B and T cells, while the combination of data 
from the B or T cells with the other groups resulted in a much smaller increase in accuracy. This suggests that the 
innate cells describe a unique variance predictive of obesity not present in the B and T datasets. The B cell data 
only made a minor contribution to the model, although in combination with data from the T cells and innate cells 
the B cell data did support the discrimination between obese and lean individuals.
To further evaluate the importance of the weights of the fusion model, we used VIP to select the cellular sub-
sets most important for discriminating between lean and obese individuals (VIP > 1). Based on this quantitative 
criterion, we found 10 cell populations relevant for the discrimination between these groups, as shown in Fig. 2 
and summarised in Table 3. The marker expressions of these cells observed in the histograms (loadings) were 
confirmed by gating the areas indicated in Fig. 2 and plotting the single-marker histograms (see Supplementary 
Methods). Obese individuals were found to possess more activated B cells (high in CD25 and CD45RO expres-
sion), activated CD4+ T cells (high in CD25, CD45RO and CD127 expression), activated natural killer cells 
(NKs), classical monocytes and non-classical monocytes (higher in CD11b, CD11c and CX3CR1 expression) 
than the lean individuals, who had more B cells and T cells high in CD38 expression, more non-activated NK 
cells, and more classical monocytes (lower in CD11b, CD11c and CX3CR1 expression). Lean individuals also 
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Figure 1. Fusion model of all the LPS aliquots after variable selection. The left panel (a) shows the LPS response 
samples in blue and the control samples in red. If the prediction score value is above the threshold, the samples 
were classified as a LPS responder. The three panels on the right (b–d) show the weights in the model of, 
respectively, aliquots 1, 2 and 3. Positive weights are coloured blue and belong to cells more represented in the 
LPS response samples, while negative weights are coloured red and belong to cells more abundant in the control 
samples. The arrows show the loadings and thus the marker expression. CM indicates mature neutrophils 
more abundant in the controls, while LM and LI respectively indicate mature and immature neutrophils more 
abundant in the LPS responders.
Dataset Accuracy Sensitivity Specificity p-value %increase
B cells 71% 80% 59% <12/1000 1.5%
T cells 79% 86% 70% <1/1000 4.5%
Innate 75% 75% 75% <9/1000 11.8%
Data fusion 81% 82% 80% <2/1000
Table 2. Performance of the DAMACY models on each dataset in the obese versus lean study, and the fusion 
of all three datasets. Accuracy indicates the percentage of correctly classified samples in the cross-validation 
study, sensitivity reflects accuracy in identifying the obese samples and specificity indicates the ability to detect 
control (lean) samples. The p-value is the relative amount of higher prediction accuracies found after 1000 
permutations. The %increase values reflect how much the accuracy would increase if that dataset was included 
in the data fusion model when compared with a fusion model comprising only the two other datasets.
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possessed more cells with a low to absent expression of the measured markers, which may be plasmacytoid den-
dritic cells (pDCs; characterised by a low expression of CD11b and CD11c). As shown by the blue and red con-
tours, some cell populations were not useful in the discrimination of obese and lean individuals, including the 
CD38−IgD+B cells, B cells with very high CD38 expression, CD8+ CD4− cells, (non)-activated intermediate 
monocytes and non-activated non-classical monocytes, in addition to the cell population which was negative for 
all markers.
Comparison with other methods. Table 4 shows the performance of different methods in the discrimination 
between lean and obese individuals. The combination of describing the cellular distribution with self-organising 
maps (SOM) and support vector machines (SVM) as classifiers resulted in an equal model performance to that 
of the fusion performed with DAMACY; however, the interpretation of the model results is considerably more 
challenging for approaches using SOM and SVM. The SOM + SVM approach resulted in three sets of 100 nodes, 
almost all of which appeared to be important for the discrimination of lean and obese individuals, as seen in Fig. 3. 
The use of Citrus circumvents the interpretation issue of having too many nodes by putting a lasso regularisation 
on the regression coefficients, resulting in only a few nodes identified as being important for discrimination. 
However, in the double cross-validation, the combination of SOM + lasso regularised logistic regression did not 
seem to perform well in terms of accuracy, despite resulting in a significant model according to the p-value. This is 
probably because the number of variables (nodes) for classification is drastically reduced in this approach, mean-
ing the heterogeneity of both classes is not captured well. Furthermore, the combination of OPLS-DA + SOM 
did not perform well, although OPLS-DA did perform well as part of the DAMACY algorithm. The histogram 
bins close to each other are highly correlated because of the smoothing step in DAMACY, and OPLS may take 
advantage of these correlations.
The DAMACY base model did not perform well using SVM as a classifier, which is probably because of the 
overfitting caused by the many correlated variables (bins). This also prevented the lasso regularised logistic regres-
sion from converging. Admire-LVQ did not perform well, possibly because of the feature extraction of every 
single marker, which means the multivariate advantage does not apply. The Admire-LVQ approach could not 
identify activated NK cells (CD11bdimCD56+CD16+), but did detect a high kurtosis of CD127 in the T cells of 
the obese individuals. To conclude, both the fusion with DAMACY and the SOM + SVM approaches performed 
well in terms of prediction accuracy; however, the fusion with DAMACY was more easily interpreted, as shown 
in Fig. 2 and Table 3.
Predicted Lean (-1)
Threshold (0)
Predicted Obese (1)
a
CD38CD45RO
CD127
CD19
CD25
IgD
b CD38
CD3 CD4
IgD
CD8
c
CX3CR1
CD14
CD11b
CD56
CD11c
CD16
HLA-DR
d
B A
C
E
F
G
H
Figure 2. Fusion model after variable selection. The left panel (a) shows the obese individuals (blue crosses) 
and the lean controls (red circles). If the predicted value was above the threshold, the individuals were classified 
as obese. The three panels on the right (b–d) present the weights in the model of, respectively, the B cell, T cell 
and innate datasets. Areas coloured blue belong to cells more abundant in obese individuals, while those in red 
belong to cells more common in lean (control) individuals. The blue contours show where, on average, 80% of 
the cells of the obese individuals lie, while the red contours indicate 80% of the cells in the lean individuals.
Aliquot Letter Cell type Marker expression More abundant in
B cells A B cells CD38+CD45RO−CD25−CD127− Lean
B cells B B cells CD38+CD45RO+CD25+CD19++CD127dim Obese
T cells C CD4+ CD8− CD38+CD45RO−CD25−CD28+CD3++ Lean
T cells D CD4+ CD8− CD38−CD45RO+CD25+CD127+CD28++CD3+ Obese
Innate E NK cells CD56+CD16+CD14−HLADR−CD11bdimCD11cdimCX3CR1dim Lean
Innate F NK cells CD56++CD16++CD14−HLADR−CD11bdim+CD11cdim+CX3CR1dim+ Obese
Innate G Classical monocytes CD56−CD16−CD14+HLADR+CD11b+CD11cdim+CX3CR1dim Lean
Innate H Activated classical monocytes CD56−CD16−CD14+HLADR++CD11b++CD11c+CX3CR1+ Obese
Innate I Activated non-classical monocytes CD56−CD16++CD14dimHLADR++CD11bdim+CD11c++CX3CR1++ Obese
Innate J plasmacytoid dendritic cells? CD11cdimCD11bdim+, rest negative Lean
Table 3. Cell populations found in Fig. 2. The expression of the markers are summarised in five different 
categories, from lowest to highest: −, dim, dim+, +, ++. The letters correspond to the same letters as in Fig. 2.
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Discussion
The data fusion extension of DAMACY shows an increased predictive and interpretative capability compared 
with the separate analyses of different measured aliquots. Although it had no increased predictive ability in the 
analysis of the LPS dataset, this approach did reveal that the marker CD64 in aliquot 2 resulted in a clear separa-
tion between two LPS-associated neutrophils, whereas the other two aliquots showed a continuum. The fusion 
guaranteed that this cellular signature is significant across all measured aliquots, but was less influenced by a 
non-discriminating cell subtype in aliquots 1 and 3. In the obese versus lean dataset, we observed a significant 
improvement in prediction using the fusion DAMACY approach, although some individuals were still misclassi-
fied. This misclassification may have occurred because those individuals are either not affected by obesity in the 
same way as the other individuals, or because their immune system is affected by something other than obesity. 
The prediction score correlated with obesity related clinical parameters such as weight, waist circumference and 
fat percentage, but not with other clinical parameters, see Supplementary Table 2. The B cells on their own were 
marginally significantly different between obese and lean people, but were found to enhance the predictive ability 
of the model when combined with the T cells or innate cells.
Variable Importance on Projection (VIP) provides a quantitative identifier for cells that are important for 
the prediction, and is calculated based on the weights of the final (O)-PLS model. Another approach is to apply 
sparsity at the same time as building the model, as is used in the lasso regularised logistic regression; however, this 
may not be sufficient to model the comprehensive biological change in the clinical phenotypes. The combination 
of fusing the histograms of the PCA models of the different measured aliquots with the application of VIP may 
help to reveal all the relevant components of the immune response that could be distinguished using the meas-
ured markers. This improved overview is provided by the generation of a map for each aliquot, in which only the 
relevant cells for either the control or the case are highlighted, overlaid with the original marker contribution as 
loadings of the PCA model.
A previous hypothesis-driven analysis of the lean versus obese dataset with sequential 2D gating in combina-
tion with univariate testing9 resulted in the same conclusions as those reported here using the DAMACY analysis, 
i.e., obese people had higher CD11b expression levels on their classical monocytes, higher CX3CR1 expression 
levels on their non-classical monocytes and relatively more NK cells. Moreover, the hypothesis-driven analysis 
also identified a higher CD11b expression level on the intermediate monocytes, which were not found to be 
discriminative in the DAMACY analysis because they were not highlighted after the VIP correction; therefore, 
the full dataset did not contain sufficient power to indicate these cells are significant contributors to prediction. 
The hypothesis-driven analysis failed to find any significant changes in the B and T cells, possibly because these 
cell populations were not significantly different between lean and obese individuals on their own; for example, 
the CD25+CD45RO+ B cells had a p-value of 0.0555 between the groups, but were predictive in combination 
Accuracy Sensitivity Specificity p-value
Fusion with DAMACY 81% 82% 80% <2/1000
SOM16 + SVM19 81% 66% 94% <1/1000
DAMACY base6 + SVM19 77% 83% 71% <1/1000
Admire-LVQ4 73% 75% 71% <13/1000
SOM16 + lasso regularised logistic regression19 73% 73% 74% <3/1000
SOM16 + OPLS-DA20 71% 66% 77% <14/1000
Table 4. Performance of the different methods on all three datasets of the lean versus obese model. Accuracy 
indicates the percentage of correctly classified samples in the cross-validation study, sensitivity reflects accuracy 
in identifying the obese samples and specificity indicates the ability to detect control (lean) samples. The p-value 
is the relative amount of higher prediction accuracies found after 1000 permutations.
Figure 3. Self-organising maps of, respectively, the B cell (a) T cell (b) and innate cell (c) datasets. The relative 
marker expression of a node is depicted as a pie chart. Blue shading behind the node indicates cell populations 
more abundant in obese individuals, while those with red shading contain cells less abundant in obese 
individuals, as predicted with SVM.
6Scientific RepoRts |          (2019) 9:6777  | https://doi.org/10.1038/s41598-019-43166-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
with other cells. The classification of the fusion model does improve (by 1.5%) when the B cell data were included, 
and the resulting model contained weights for this dataset. Supplementary Fig. 9 shows how these cells (B in 
Fig. 2) may help to separate the lean and obese individuals when combined with the non-classical monocytes 
(I in Fig. 2). Another reason could be that the specific subset was not tested in the hypothesis-driven analysis, 
as was the case for the increased abundance of CD25− CD45RO− B cells (p-value 0.0024) and CD4+CD38− 
CD45RO+CD25+CD127+ T cells (p-value 8.3e-4) and the decreased amount of CD4+CD38+CD45RO− 
CD25−CD127− T cells (p-value 0.0011) in the obese individuals. For this reason, a data-driven approach is 
better suited to the study of currently unknown interactions between cells, as it will detect all cell types with 
significant differences in abundance between the studied clinical phenotypes, whereas hypothesis-driven research 
will only identify differences in the cells that are tested.
Multivariate analysis methods observe the expression of all markers on all cells for every patient. The impor-
tance of the cells within the model is then determined by (1) their marker expression in relation to the investi-
gated immune response or (2) their co-occurrence with other cells. Standard multivariate methods, including 
SVM, SOM, PCA, and PLS, provide a readout of the relative importance of every cell in the model, which leads 
to a data-dense representation (see e.g., Fig. 3) from which the dedicated immunological information may be 
challenging to interpret. Sparse methods, such as the lasso regularised logistic regression used in Citrus, have 
been developed to specifically provide descriptive models for an immune response involving as few cell types as 
possible. The resulting minimal set of cells is much easier to interpret than results from the standard methods, but 
do not contain the comprehensive set of cells involved in the response. Immune responses may consist of highly 
specific mechanisms, but may also involve generic mechanisms such as normal inflammatory markers that may 
be induced for many different immune responses; the involvement of both aspects in the immune response are 
therefore redundant. Sparse models do not distinguish between the specificity of such patterns in a binary com-
parison, such that strongly responding but highly generic cells may be identified as the most characteristic for a 
studied response. Second, and most characteristic in our study, is that the sparsity criterion may select different 
redundant cells for different realisations within the double cross-validation.
The optimal cell set from a comprehensive cell characterisation would include only the relevant compre-
hensive subset for the response. DAMACY, specifically involving OPLS as the top model, is among the most 
appropriate of the described methods for this aim. The method is data-driven, and thus may also identify unex-
plored relationships between (sub)types of cells and the studied response. OPLS removes the orthogonal informa-
tion and, together with VIP, only shows the relevant cellular variability. Finally, complementary cell data may be 
merged in a multiblock sense, and may also be extended to clinical or other omics data. The set of cells identified 
using DAMACY may then be considered to represent all cells that are significantly involved. This may be com-
pared to the objective of metabolomics, which (1) aims to measure all small organic metabolites and (2) tries to 
identify all chemical species involved in the studied biological process. Analogously, the cell set resulting from 
the DAMACY analysis will be optimally informative for further immunological studies on the variability of, and 
mechanisms underlying, the studied response.
Conclusion
The data fusion extension of the DAMACY method can be used to effectively discriminate clinical phenotypes 
from flow cytometry data with multiple aliquot measurements using different panels. The method uses correla-
tions between cell subtypes and generates a cell map for each aliquot with only the relevant cells highlighted for 
discriminating between the clinical phenotypes. The original (co-)expression of the marker is overlaid as a vector 
on the map, enabling researchers to clearly observe which cells are important for the clinical phenotypes and their 
(co-)expression. This data fusion method performs equally well or better than the best DAMACY model using a 
single aliquot, as statistically tested with a double cross-validation and permutation testing.
Methods
Data. Peripheral blood was extracted from subjects in both the LPS challenge study and obese versus lean 
study, all of whom gave their written informed consent before participating. All data were obtained using stand-
ardised protocols. The LPS challenge study and sample collection were approved by the medical ethics committee 
of Radboud University Medical Center (Radboudumc) Nijmegen, The Netherlands. The study protocol of the 
obese versus lean study was approved by the Medical Ethical Committee Jessa hospital, Hasselt, and Hasselt 
University, Belgium. Both studies were performed in accordance with the Declaration of Helsinki (Forteleza, 
2013).
LPS data. In total, blood samples were taken from 16 individuals before and after 180 minutes of LPS adminis-
tration. Three aliquots containing the following markers were measured:
Aliquot 1: CD182, CD181, CD62L, CD66b, PDL-1, LAIR-1, CBRM1/5, CD11b, CD54, CD16;
Aliquot 2: CD35, TLR-4, CD62L, CD11c, CD49d, CD32, CBRM1/5, CD11b, CD64, CD16;
Aliquot 3: CD88, CD181, CD62L, CD66b, CD49d, CD182, CD11b, CD16.
The data were gated for neutrophils using forward, sideward scatter, and CD16 expression using a standard 
protocol.
Obesity versus lean data. In total, blood was extracted from 31 individuals, of whom 13 were lean with a body 
mass index (BMI) of between 20.83 and 25.62, and 16 were obese with a BMI between 30.47 and 49.279. Two 
aliquots containing the following markers were measured:
Aliquot 1: CD38, CD4, CD45RO, CD127, CD28/IgD, CD25, CD8/CD19, CD3;
Aliquot 2: CXRCR1, CD14, CD56, CD11c, CD16, HLA-DR, CD3/CD19/CD66b.
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Aliquot 1 contains specific antibodies for B cells and T cells on the same fluorophore, and was split to simplify 
the interpretation of the data by gating for B cells (CD19+CD3−) and T cells (CD3+). The gated data contained 
the following markers:
B cells: CD38, CD45RO, CD127, IgD, CD25, CD19;
T cells: CD38, CD4, CD45RO, CD127, CD28, CD25, CD8, CD3.
Aliquot 2 was gated for innate cells by removing all cells positive for the markers CD3, CD19 and CD66b.
Experimental method. In this paper, the fusion of the histograms in DAMACY are compared with the predic-
tion with extracted features in Admire-LVQ4, and with the approaches in which the data are first clustered using 
SOMs and subsequently classified using OPLS-DA, SVM or a lasso regularised logistic regression. SOM was 
selected because it has been proven to be a very effective clustering method, both in terms of describing the data 
and speed10,11, which is required to effectively cross-validate the algorithms. SVM successfully classified data in 
the Flowcap 2 challenge5, while the lasso regularised logistic regression successfully classified data in Citrus12. 
Both the prediction performance and the interpretation of the visualized data were compared.
Cross-validation and permutation. The data were split into training and test sets using a five-fold cross-validation 
across 50 iterations. The data were thus randomly stratified into five parts, four of which were used to train each 
model, while the fifth was used to assess the model performance. This was repeated such that all parts were used 
once to assess the model performance. The stratified random splitting of the data into five parts was repeated 
50 times13. The composition of the training and test sets were stored and reused to assess the performance of 
each method, resulting in a fairer comparison between the methods. OPLS involves an internal leave-one-out 
cross-validation to determine the number of orthogonal latent variables, while the lasso regularised logistic 
regression had an internal ten-fold cross-validation to determine lambda14.
Permutation testing was applied to determine whether the built models predicted an actual effect or random 
effect. The labels were randomly permuted 1000 times and models were built to classify the random effects. In 
OPLS, the same number of orthogonal latent variables were used as determined in the model, while in lasso the 
same lambda was used, so that an internal cross-validation loop was not required. A p-value can be calculated 
by counting the number of times the accuracy of a random effect is equal to or higher than the accuracy of the 
studied effect and dividing by the total number of permutations, in this case 1000 (see Eq. 1)14.
<
∑ ≥ +
p
accuracy accuracy( ) 1
1000 (1)
permutated model
Pre-processing of the data. The data of each aliquot measurement were transformed using the hyperbolic inverse 
sine with a cofactor of 150. In the case of the obese versus lean study, the data were transformed with median cen-
tring using the median marker expression of all lean individuals from the training set, and subsequently scaled by 
dividing every marker by its standard deviation in the lean individuals from the training set. In the case of the LPS 
dataset, each measurement was centred and scaled using the median and standard deviation of each individual 
from the measurements both before and after LPS.
Adaption of DAMACY. After pre-processing, a PCA model was built on the concatenated training data, and all 
individuals were projected into the principal component space. A 2D histogram was calculated on the PCA scores 
of each aliquot, as described in the original DAMACY paper6 and summarised in the supplementary material of 
this manuscript. The histograms of each aliquot were smoothed and normalised to the unit sum of all bins, after 
which the unfolded histograms of each aliquot were concatenated into one large matrix (see Eq. 2).
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where Hifm is a bin (f) in the unfolded histogram (m) of individual = …i I1 , I is the total number of individuals, 
= …f F1 2, F is the total number of bins in one dimension of the histogram of aliquot m M1= …  and M is the 
total number of different measured aliquots. The default F value used is F = 500, but in this article 100 bins were 
used, because the number of cells per sample was relatively low (<10,000).
The large matrix H was mean-centred using the mean of the training set. An OPLS-DA model was built using 
the training data of H and the logical dummy vector with length I*, where I* is the number of individuals in the 
training data. A final model was then built on all samples, giving the weight vector wtop, which can be refolded into 
an × ×F F M( ) matrix Wtop when the number of principal components is K 2base =  in the base model. After 
building the OPLS-DA model, the VIP15 was calculated for each bin weight, using Eq. 3. Weights (histogram bins) 
with a VIP lower than one were set to zero, while weights with a VIP greater than one were the histogram bins that 
contributed significantly to the model.
= × wFVIP (3)top
2⁎
The matrix Wtop corresponds to the original M histograms Him, forming a leukocyte map for each aliquot (see 
Figs 1 and 2). This map shows which histogram bins, hence which cells, are over- or underrepresented in either 
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group, and can therefore be interpreted together with the mean predictive scores of yˆ. Each single cell positively 
or negatively alters the individual score when it ends up in a positively or negatively weighted bin in the leukocyte 
map. Finally, a prediction score yˆ was calculated for each individual in the test set. The whole algorithm was 
repeated until every iteration of the training set matrix was used. This resulted in 50 values of yˆ for each individ-
ual. The mean value was plotted as the mean prediction score.
Self-organising maps. The SOMs were built on the training data of each aliquot using the Matlab toolbox for 
SOMs16, with the same default setting as flowSOM10, including the Euclidian distance, a grid size of 10 by 10 
nodes, and the batch training algorithm with a number of steps 10 times greater than the number of cells in the 
training set. Finally, the number of cells per node was calculated for all samples using the nearest neighbour, 
resulting in a large matrix with a size of I × 100 M, where I is the total number of individuals and M is the number 
of aliquots.
Classifiers on self-organising map nodes. Three classifiers were tested on the large matrix; SVMs, as used in flow-
peakSVM3,5, the lasso regularised logistic regression used in Citrus12 and the OPLS-DA in DAMACY6. For the 
SVM, a linear kernel and a box constraint of one were used. The regression coefficients of SVM, the regression 
coefficients with lambda and the minimum deviance in the inner cross-validation loop of the lasso regularised 
logistic regression, and the weights of the OPLS-DA model with the number of orthogonal variables that gave 
the minimum error in the inner cross-validation loop were used for visualization. A minimum spanning tree was 
built for each SOM using the kamada and kawai algorithms17, as used in flowSOM10 and SPADE18. Each node was 
coloured according to its regression coefficient or weight and the mean marker expression as a pie chart.
Data Availability
The datasets generated and/or analysed during the current study are available from the corresponding author 
upon reasonable request.
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